We've found
52,953 Cancer
clinical trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Tumors Clinical Trial
Proton Radiotherapy for Recurrent Tumors
Status: Enrolling,
Phase
I, II
Updated: 1/26/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cervical Cancer Clinical Trial
Conservative Surgery for Women With Cervical Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Status: Enrolling,
Phase
I
Updated: 10/11/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Status: Enrolling,
Phase
I
Updated: 10/11/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Status: Enrolling,
Phase
I
Updated: 10/11/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Status: Enrolling,
Phase
I
Updated: 10/11/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Status: Enrolling,
Phase
I
Updated: 10/11/2012
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line
Status: Enrolling,
Phase
II
Updated: 9/19/2013
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line
Status: Enrolling,
Phase
II
Updated: 9/19/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma
Status: Enrolling
Updated: 1/8/2013
Click here to add this to my saved trials
Sarcoma Clinical Trial
Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Status: Enrolling
Updated: 4/16/2010
Click here to add this to my saved trials
Sarcoma Clinical Trial
Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Status: Enrolling
Updated: 4/16/2010
Click here to add this to my saved trials
Sarcoma Clinical Trial
Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Status: Enrolling
Updated: 4/16/2010
Click here to add this to my saved trials
Sarcoma Clinical Trial
Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Status: Enrolling
Updated: 4/16/2010
Click here to add this to my saved trials
Oncology Clinical Trial
RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By Surgery
Status: Enrolling,
Phase
I
Updated: 9/23/2013
Click here to add this to my saved trials
Lobular Breast Carcinoma in Situ Clinical Trial
Letrozole in Treating Healthy Postmenopausal Women at High Risk for Breast Cancer
Status: Enrolling,
Phase
I
Updated: 11/25/2013
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 10/6/2011
Click here to add this to my saved trials
Oncology Clinical Trial
Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Incontinent Urinary Diversion Using an Autologous Neo-Urinary Conduit
Status: Enrolling,
Phase
I
Updated: 5/2/2013
Click here to add this to my saved trials
We've found
52,953 Cancer
clinical trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Tumors Clinical Trial
Updated: 1/26/2016
Proton Radiotherapy for Recurrent Tumors
Status: Enrolling,
Phase
I, II
Updated: 1/26/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cervical Cancer Clinical Trial
Updated: 12/31/1969
Conservative Surgery for Women With Cervical Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 10/11/2012
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Status: Enrolling,
Phase
I
Updated: 10/11/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 10/11/2012
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Status: Enrolling,
Phase
I
Updated: 10/11/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 10/11/2012
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Status: Enrolling,
Phase
I
Updated: 10/11/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 10/11/2012
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Status: Enrolling,
Phase
I
Updated: 10/11/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 10/11/2012
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Status: Enrolling,
Phase
I
Updated: 10/11/2012
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 9/19/2013
GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line
Status: Enrolling,
Phase
II
Updated: 9/19/2013
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 9/19/2013
GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line
Status: Enrolling,
Phase
II
Updated: 9/19/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/22/2013
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 1/8/2013
Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma
Status: Enrolling
Updated: 1/8/2013
Click here to add this to my saved trials
Sarcoma Clinical Trial
Updated: 4/16/2010
Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Status: Enrolling
Updated: 4/16/2010
Click here to add this to my saved trials
Sarcoma Clinical Trial
Updated: 4/16/2010
Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Status: Enrolling
Updated: 4/16/2010
Click here to add this to my saved trials
Sarcoma Clinical Trial
Updated: 4/16/2010
Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Status: Enrolling
Updated: 4/16/2010
Click here to add this to my saved trials
Sarcoma Clinical Trial
Updated: 4/16/2010
Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Status: Enrolling
Updated: 4/16/2010
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 9/23/2013
RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By Surgery
Status: Enrolling,
Phase
I
Updated: 9/23/2013
Click here to add this to my saved trials
Lobular Breast Carcinoma in Situ Clinical Trial
Updated: 11/25/2013
Letrozole in Treating Healthy Postmenopausal Women at High Risk for Breast Cancer
Status: Enrolling,
Phase
I
Updated: 11/25/2013
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Updated: 10/6/2011
Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 10/6/2011
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Updated: 5/2/2013
Incontinent Urinary Diversion Using an Autologous Neo-Urinary Conduit
Status: Enrolling,
Phase
I
Updated: 5/2/2013
Click here to add this to my saved trials